Skip to Main Content

Paper Details

Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion.
Pharmaceuticals (Basel)
2
2022
Author NameAffiliation
Susan M SheaWashington University in St. Louis School of Medicine
Kimberly A ThomasWashington University in St. Louis School of Medicine
Philip C SpinellaWashington University in St. Louis School of Medicine
  • 1 - 3

Datasets

Release 1.2